decisionhealth Newsletters, Part B News - 2017 Issue 1 (January)
ICD-10-CM coding for tamoxifen depends on intent of the therapy
Subscribe or sign in to view the full article.
Article Overview
This article addresses ICD-10-CM coding considerations for a patient with prior breast cancer who is receiving tamoxifen after mastectomy. It explains why the documented intent of the therapy matters and references guidance tied to oncologic follow-up, history codes, and long-term medication use categories. The piece is relevant to coders, billers, and clinicians documenting cancer treatment status and medication purpose.
Why This Topic Matters
Correct coding depends on whether therapy is being used as part of ongoing cancer treatment or as preventive follow-up after cancer treatment. That documentation affects how the diagnosis picture is represented in claims and records.
What You Will Learn
- How the documented intent of anti-estrogen therapy affects coding context
- How breast cancer history and active disease status are distinguished in coding
- How long-term medication use categories may be referenced in this scenario
- What documentation elements are important for assigning diagnosis codes in follow-up care
Who Should Read This
- Medical coders
- Medical billers
- Oncology practices
- Gynecology practices
- Compliance staff
- Clinical documentation specialists
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com